Breast implants are not considered 'lifetime devices.' While some patients keep them for years without issues, others may require revisions sooner due to complications such as rupture or capsular contracture. Regular follow-ups are essential to address any changes rather than waiting for an 'expiration date.' For more details on long-term considerations, refer to the FDA's overview of breast implant risks and complications.

Silicone implant ruptures can be “silent,” meaning you may not experience symptoms immediately. Medical guidelines commonly reference imaging surveillance (MRI or ultrasound) beginning several years after surgery and then periodically thereafter. Dr. Piazza will advise you on a monitoring plan tailored to your implant type and history.

Yes. You can—and should—continue age-appropriate breast cancer screening. Implants may require additional “implant displacement” views so the technologist can better visualize breast tissue. It’s essential to inform the imaging center that you have implants when booking.

Many women can breastfeed after augmentation, but there are no guarantees. Breastfeeding outcomes vary based on your anatomy, surgical approach, incision location, and the presence of glandular tissue. The FDA notes that changes in sensation and breastfeeding-related outcomes are considerations to discuss before surgery.

Pregnancy and weight changes can alter breast volume and skin elasticity, sometimes leading to new sagging or shape changes, regardless of the technique used. If that happens, options may include a breast lift, implant adjustment, or revision. The key is planning your starting size and tissue tolerance with long-term life changes in mind.

Most augmentation scars are designed to be discreet, commonly placed in the inframammary fold (the natural crease under the breast). Scar quality depends on your healing biology, incision care, sun exposure, and factors like smoking history. The FDA lists scarring and other local tissue effects among potential outcomes and complications.

Implants can make mammography more technically complex, which is why specialized imaging views are used. This is a screening logistics issue—not a reason to avoid implants. The most important steps are (1) telling your imaging center you have implants and (2) keeping routine screening appointments.

All surgery carries risk. Potential complications include infection, bleeding/hematoma, seroma (fluid collection), wound healing issues, scarring, and anesthesia-related risks. Implant-specific risks can include capsular contracture, rupture, changes in nipple/breast sensation, rippling, malposition, and the need for future revision surgery. The FDA also highlights rare but serious conditions, including breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) and other breast implant-associated malignancies and systemic symptom reports sometimes referred to as breast implant illness (BII).

In the U.S., the FDA approval framework generally distinguishes age considerations by implant type/indication; for silicone gel-filled implants used for augmentation, the commonly referenced threshold is 22 years and older. Your candidacy still depends on health, anatomy, and informed consent.